-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Importance: Older adults vary greatly in the age of diagnosis and the duration of type 2 diabetes, but treatment often ignores this heterogeneity
ObjectiveTo investigate the relationship between
Design, Setup, and Participants: This cohort study included participants in the Health and Retirement Study (HRS) wave from 1995 to 2018, a population-based two-year longitudinal health interview survey
Exposure: The presence of diabetes, particularly at the age of diabetes diagnosis, was the main exposure
Key Results and Measurements: For each diabetes diagnostic age group, a control group with a preference score match was constructed consisting
Results: A total of 7739 HRS responders developed diabetes mellitus and were included in the analysis (4267 women [55.
Figure 1 Incidence of distal outcomes for each diabetes diagnostic age group and its matching control group (MC).
Figure 2 Cumulative incidence curve of distal results for each diabetes diagnostic age group and its matching control group (MC).
Figure 3 Diabetes Diagnosis by Age Group, Ratio of Harm to Distal Results (HR) of Diabetes Compared to Matched Control Groups (MCs)
Conclusions: The results of this cohort study suggest that there is a difference in age and prognosis for diabetes diagnosis, with a higher
Source: Cigolle CT, Blaum CS, Lyu C,et al.